Swedbank AB Sells 570 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Swedbank AB reduced its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,390 shares of the medical instruments supplier’s stock after selling 570 shares during the quarter. Swedbank AB owned approximately 0.09% of Mettler-Toledo International worth $23,727,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. raised its stake in shares of Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 17 shares during the last quarter. Ashton Thomas Securities LLC bought a new position in Mettler-Toledo International during the 3rd quarter valued at approximately $37,000. Raleigh Capital Management Inc. lifted its holdings in Mettler-Toledo International by 272.7% in the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 30 shares during the period. Sound Income Strategies LLC grew its position in shares of Mettler-Toledo International by 4,500.0% in the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock worth $56,000 after buying an additional 45 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. increased its stake in shares of Mettler-Toledo International by 60.0% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock valued at $72,000 after buying an additional 18 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Wall Street Analyst Weigh In

MTD has been the subject of a number of research analyst reports. Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Wells Fargo & Company reduced their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Finally, Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $1,351.25.

Mettler-Toledo International Trading Up 2.0 %

Shares of NYSE:MTD opened at $1,362.71 on Friday. Mettler-Toledo International Inc. has a 12-month low of $1,133.46 and a 12-month high of $1,546.93. The stock has a market capitalization of $28.75 billion, a price-to-earnings ratio of 36.74, a PEG ratio of 4.19 and a beta of 1.12. The stock has a fifty day simple moving average of $1,260.70 and a two-hundred day simple moving average of $1,343.47.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. As a group, equities research analysts predict that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Elisha W. Finney sold 76 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.